Wu Xiaoping

Dr. Wu Xiaoping is a senior patent counsel at Wanhuida Intellectual Property. She has handled a substantial number of patent prosecution, invalidation, administrative, and infringement litigation cases. Xiaoping has a profound understanding of the substance of China’s Patent Law and deep technical expertise in chemical engineering, inorganic/organic chemical engineering, and organic chemistry.

She successfully defended the validity of the patent concerning the formulation of amlodipine and irbesartan compound preparation in Simcere v Patent Reexamination Board (the predecessor of the Patent Reexamination and Invalidation Department of the China National Intellectual Property Administration) in the administrative retrial litigation before the Supreme People’s Court (SPC), a case selected to be included in the SPC’s Annual Report on Intellectual Property Cases of the Year.

In the past few years, Xiaoping has been honing her skill set in litigating pharmaceutical invention patent disputes and has developed an insight into judicial practice in the pharmaceutical field.